Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Inventory Average for 4 consecutive years, with $6.0 million as the latest value for Q1 2026.

  • For Q1 2026, Inventory Average rose 88.67% year-over-year to $6.0 million; the TTM value through Mar 2026 reached $6.0 million, up 88.67%, while the annual FY2025 figure was $4.4 million, 97.6% up from the prior year.
  • Inventory Average hit $6.0 million in Q1 2026 for Phathom Pharmaceuticals, up from $4.6 million in the prior quarter.
  • Across five years, Inventory Average topped out at $6.0 million in Q1 2026 and bottomed at $111000.0 in Q3 2023.
  • Average Inventory Average over 4 years is $2.8 million, with a median of $3.2 million recorded in 2024.
  • Year-over-year, Inventory Average skyrocketed 2281.98% in 2024 and then surged 33.17% in 2025.
  • Phathom Pharmaceuticals' Inventory Average stood at $659500.0 in 2023, then skyrocketed by 379.08% to $3.2 million in 2024, then surged by 44.47% to $4.6 million in 2025, then surged by 31.73% to $6.0 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods came in at $6.0 million, $4.6 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.